TipRanks
SAB Biotherapeutics (SABS)
NASDAQ:SABS
US Market
SABS
SAB Biotherapeutics
RESEARCH TOOLSreports
Want to see SABS full AI Analyst Report?

SAB Biotherapeutics (SABS) Stock News & Sentiment

328 Followers
SAB Biotherapeutics Wins FDA Fast Track for SAB-142
Premium
Company Announcements
SAB Biotherapeutics Wins FDA Fast Track for SAB-142
18d ago
8K
SABS
SAB Biotherapeutics advances SAB-142 Type 1 diabetes trial
Premium
Company Announcements
SAB Biotherapeutics advances SAB-142 Type 1 diabetes trial
4M ago
8K
SABS
SAB Biotherapeutics Shareholders Back Board and Auditor
Premium
Company Announcements
SAB Biotherapeutics Shareholders Back Board and Auditor
4M ago
8K
SABS
SAB Biotherapeutics Reaffirmed Buy/High Risk on Regulatory Derisking, Positive SAB-142 Data and Unchanged $11 Price Target
Premium
Ratings
SAB Biotherapeutics Reaffirmed Buy/High Risk on Regulatory Derisking, Positive SAB-142 Data and Unchanged $11 Price Target
5M ago
SABS
SAB Biotherapeutics: Buy Rating Reiterated as Tzield Approval De-Risks SAB-142, $10 Price Target Maintained
Premium
Ratings
SAB Biotherapeutics: Buy Rating Reiterated as Tzield Approval De-Risks SAB-142, $10 Price Target Maintained
5M ago
SABS
SAB Biotherapeutics Signs Manufacturing Pact for SAB-142
Premium
Company Announcements
SAB Biotherapeutics Signs Manufacturing Pact for SAB-142
6M ago
8K
SABS
Buy Rating on SABS Driven by SAB-142’s Differentiated T1D Mechanism, Durable C‑Peptide Preservation, and Pivotal SAFEGUARD Catalyst
Premium
Ratings
Buy Rating on SABS Driven by SAB-142’s Differentiated T1D Mechanism, Durable C‑Peptide Preservation, and Pivotal SAFEGUARD Catalyst
6M ago
SABS
More SABS News >

SABS News on the Web

SAB Biotherapeutics Inc at Citi Biopharma Back to School Summit Transcript
GuruFocus News
Neutral
Analysts Offer Insights on Healthcare Companies: Denali Therapeutics (DNLI) and SAB Biotherapeutics (SABS)
TipRanks News
Bullish
SAB Biotherapeutics initiated with an Overweight at Barclays
TipRanks News
Bullish
SAB Biotherapeutics Shareholders Back Board and Auditor
TipRanks News
Neutral
Analysts Are Bullish on Top Healthcare Stocks: Ryman Healthcare (RHCGF), SAB Biotherapeutics (SABS)
TipRanks News
Bullish
SAB Biotherapeutics Reaffirmed Buy/High Risk on Regulatory Derisking, Positive SAB-142 Data and Unchanged $11 Price Target
TipRanks News
Neutral
Analysts Offer Insights on Healthcare Companies: Halozyme (HALO), SAB Biotherapeutics (SABS) and Design Therapeutics (DSGN)
TipRanks News
Neutral
SAB Biotherapeutics initiated with a Buy at Citi
TipRanks News
Bullish

News Score - Last 7 Days

Not enough data to generate a sentiment score
Media Buzz
This Week0 articles
Weekly Average0.75 articles
News Sentiment
Currently, no data available
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is SABS’s Media Buzz Sentiment?
Currently, no data Available
What is SABS’s weekly average amount of articles?
In an average week, 0.75 articles about SABS are published.
    What is SABS’s News Sentiment?
    Currently, no data Available
    Healthcare Stocks that are Trending in the News
    CNCCentene
    GMABGenmab
    LHLabcorp Holdings
    KIDSOrthoPediatrics
    DXCMDexcom
    Showing the stocks with the most bullish news sentiment over the past week